A new study out of Stanford university shows promise at completly killing off the disease-causing bacteria borrelia burgdorferi. This disease-causing agent was typically prescribed common antibiotics to fight the infection. For 20% of those patients the standard antibiotics did not work.
For those 20% of people antibiotics don’t work, and lingering symptoms of muscle pain, fatigue and cognitive impairment can continue for years.
The new drug azlocillin showed 100% efficacy in rats at the onset of the disease.